This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ozempic, a prescription medication used to treat type 2 diabetes. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The current delivery order has a ceiling value of $13,134.56 and is a firm fixed price contract with a completion date of December 6, 2024. The contract did not have a set-aside designation, indicating open competition.
Generated 3/6/25, 9:55 AM